Compare appetite‑suppressing topiramate and fat‑blocking Orlistat — effectiveness, weight‑loss outcomes, safety insights, side‑effect patterns, pricing differences, and which option offers stronger value for your goals.
See Full ComparisonTopiramate is an anticonvulsant used off-label for weight loss due to its appetite-suppressing effects, while Orlistat is an FDA-approved medication that blocks fat absorption in the digestive system. Topiramate may reduce food cravings, whereas Orlistat works directly on dietary fat intake.
| Feature | Topiramate ⭐ Off-label | Orlistat ⭐ Fat Blocker |
|---|---|---|
| Rating |
★★★☆☆
|
★★★☆☆
|
| Weight Loss | 5–10% | 5–7% |
| Mechanism | Appetite suppression (CNS) | Blocks fat absorption |
| Usage | Daily tablets | Daily capsules |
| Approval | Not approved for weight loss | Approved for weight loss |
| Cost | Low | Low–moderate |
| Best for | Reducing appetite & cravings | Reducing fat absorption |
| Check Options | Check Options | Check Options |
| Details | View Topiramate | View Orlistat |
Topiramate may be more effective for appetite control and reducing cravings, while Orlistat is better suited for blocking fat absorption from meals. The best choice depends on whether you struggle more with overeating or high-fat diets.
Compare Best OptionCons: Off-label use, neurological side effects
Cons: Digestive side effects, lower effectiveness